[Glutathione metabolism during postnatal development of the rat lung]

Alejandro Ramírez1, Tatiana Reyes, Leonel Liberona

  • 1Departamento de Enfermedades Respiratorias, Pontificia Universidad Católica de Chile, Santiago, Chile.

Revista Medica De Chile
|October 5, 2007
PubMed

Insights

Lung antioxidant systems, including glutathione peroxidase (GPx) and glutathione reductase (GRd), significantly increase during postnatal development in rats. Understanding these physiological changes is crucial for interpreting lung responses to injury.

Area of Science:

  • Biochemistry
  • Pulmonary Medicine
  • Developmental Biology

Context:

  • Lung antioxidant systems undergo significant changes during the perinatal period.
  • Postnatal physiological regulation of lung antioxidants remains poorly understood.

Purpose:

  • To investigate the developmental changes in the glutathione system within the rat lung post-birth.
  • To measure key glutathione pathway enzymes and glutathione levels at various postnatal ages.

Summary:

  • Glutathione peroxidase (GPx) and glutathione reductase (GRd) activities increase significantly between 7 and 15 days postnatally.
  • Gamma-glutamylcysteine synthetase (y-GCS) activity gradually increases, doubling by 50 days.
  • Total glutathione (GSH) remains stable, while oxidized glutathione decreases postnatally.

Impact:

  • This study elucidates the dynamic regulation of lung antioxidant defenses during postnatal development.
  • Findings highlight the importance of considering developmental changes in antioxidant capacity when evaluating lung injury responses.
Abstract

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...